The report titled Global Cell Freezing Media for Cell Therapy Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Cell Freezing Media for Cell Therapy market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Cell Freezing Media for Cell Therapy market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Cell Freezing Media for Cell Therapy market is carefully analyzed and researched about by the market analysts.
Key companies operating in the global Cell Freezing Media for Cell Therapymarket include_BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq, WAK-Chemie Medical, Biological Industries, Akron Biotechnology
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
Segmental Analysis :
The report has classified the global Cell Freezing Media for Cell Therapy industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Cell Freezing Media for Cell Therapy manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Cell Freezing Media for Cell Therapy industry.
Global Cell Freezing Media for Cell Therapy Market Segment By Type:
With FBS, Without FBS
Global Cell Freezing Media for Cell Therapy Market Segment By Applications:
Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Other
Critical questions addressed by the Cell Freezing Media for Cell Therapy Market report
Reasons to Buy the Report
Get Full Customize report now at :https://www.qyresearch.com/customize-request/form/1548125/global-cell-freezing-media-for-cell-therapy-market
Table of Contents1 Cell Freezing Media for Cell Therapy Market Overview1.1 Cell Freezing Media for Cell Therapy Product Overview1.2 Cell Freezing Media for Cell Therapy Market Segment by Type1.2.1 With FBS1.2.2 Without FBS1.3 Global Cell Freezing Media for Cell Therapy Market Size by Type (2015-2026)1.3.1 Global Cell Freezing Media for Cell Therapy Market Size Overview by Type (2015-2026)1.3.2 Global Cell Freezing Media for Cell Therapy Historic Market Size Review by Type (2015-2020)1.3.2.1 Global Cell Freezing Media for Cell Therapy Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global Cell Freezing Media for Cell Therapy Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global Cell Freezing Media for Cell Therapy Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Cell Freezing Media for Cell Therapy Market Size Forecast by Type (2021-2026)1.3.3.1 Global Cell Freezing Media for Cell Therapy Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global Cell Freezing Media for Cell Therapy Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global Cell Freezing Media for Cell Therapy Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Cell Freezing Media for Cell Therapy Sales Breakdown by Type (2015-2026)1.4.2 Europe Cell Freezing Media for Cell Therapy Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Cell Freezing Media for Cell Therapy Sales Breakdown by Type (2015-2026)1.4.4 Latin America Cell Freezing Media for Cell Therapy Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Cell Freezing Media for Cell Therapy Sales Breakdown by Type (2015-2026) 2 Global Cell Freezing Media for Cell Therapy Market Competition by Company2.1 Global Top Players by Cell Freezing Media for Cell Therapy Sales (2015-2020)2.2 Global Top Players by Cell Freezing Media for Cell Therapy Revenue (2015-2020)2.3 Global Top Players Cell Freezing Media for Cell Therapy Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Cell Freezing Media for Cell Therapy Manufacturing Base Distribution, Sales Area, Product Type2.5 Cell Freezing Media for Cell Therapy Market Competitive Situation and Trends2.5.1 Cell Freezing Media for Cell Therapy Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Cell Freezing Media for Cell Therapy Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Freezing Media for Cell Therapy as of 2019)2.7 Date of Key Manufacturers Enter into Cell Freezing Media for Cell Therapy Market2.8 Key Manufacturers Cell Freezing Media for Cell Therapy Product Offered2.9 Mergers & Acquisitions, Expansion 3 Global Cell Freezing Media for Cell Therapy Status and Outlook by Region (2015-2026)3.1 Global Cell Freezing Media for Cell Therapy Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Cell Freezing Media for Cell Therapy Market Size Market Share by Region (2015-2020)3.2.1 Global Cell Freezing Media for Cell Therapy Sales Market Share by Region (2015-2020)3.2.2 Global Cell Freezing Media for Cell Therapy Revenue Market Share by Region (2015-2020)3.2.3 Global Cell Freezing Media for Cell Therapy Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Cell Freezing Media for Cell Therapy Market Size Market Share by Region (2021-2026)3.3.1 Global Cell Freezing Media for Cell Therapy Sales Market Share by Region (2021-2026)3.3.2 Global Cell Freezing Media for Cell Therapy Revenue Market Share by Region (2021-2026)3.3.3 Global Cell Freezing Media for Cell Therapy Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)3.4.1 North America Cell Freezing Media for Cell Therapy Revenue YoY Growth (2015-2026)3.4.2 North America Cell Freezing Media for Cell Therapy Sales YoY Growth (2015-2026)3.5 Asia-Pacific Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Cell Freezing Media for Cell Therapy Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Cell Freezing Media for Cell Therapy Sales YoY Growth (2015-2026)3.6 Europe Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)3.6.1 Europe Cell Freezing Media for Cell Therapy Revenue YoY Growth (2015-2026)3.6.2 Europe Cell Freezing Media for Cell Therapy Sales YoY Growth (2015-2026)3.7 Latin America Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)3.7.1 Latin America Cell Freezing Media for Cell Therapy Revenue YoY Growth (2015-2026)3.7.2 Latin America Cell Freezing Media for Cell Therapy Sales YoY Growth (2015-2026)3.8 Middle East and Africa Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Cell Freezing Media for Cell Therapy Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Cell Freezing Media for Cell Therapy Sales YoY Growth (2015-2026) 4 Global Cell Freezing Media for Cell Therapy by Application4.1 Cell Freezing Media for Cell Therapy Segment by Application4.1.1 Human Embryonic Stem Cells4.1.2 CAR-T Cell Therapy4.1.3 Neural Stem Cell Therapy4.1.4 Mesenchymal Stem Cell Therapy4.1.5 Hematopoietic Stem Cell Transplantation4.1.6 Other4.2 Global Cell Freezing Media for Cell Therapy Sales by Application: 2015 VS 2020 VS 20264.3 Global Cell Freezing Media for Cell Therapy Historic Sales by Application (2015-2020)4.4 Global Cell Freezing Media for Cell Therapy Forecasted Sales by Application (2021-2026)4.5 Key Regions Cell Freezing Media for Cell Therapy Market Size by Application4.5.1 North America Cell Freezing Media for Cell Therapy by Application4.5.2 Europe Cell Freezing Media for Cell Therapy by Application4.5.3 Asia-Pacific Cell Freezing Media for Cell Therapy by Application4.5.4 Latin America Cell Freezing Media for Cell Therapy by Application4.5.5 Middle East and Africa Cell Freezing Media for Cell Therapy by Application 5 North America Cell Freezing Media for Cell Therapy Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Cell Freezing Media for Cell Therapy Sales Market Share by Country (2015-2020)5.1.2 North America Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Cell Freezing Media for Cell Therapy Sales Market Share by Country (2021-2026)5.2.2 North America Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)5.3.2 Canada Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026) 6 Europe Cell Freezing Media for Cell Therapy Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Cell Freezing Media for Cell Therapy Sales Market Share by Country (2015-2020)6.1.2 Europe Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Cell Freezing Media for Cell Therapy Sales Market Share by Country (2021-2026)6.2.2 Europe Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)6.3.2 France Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)6.3.3 U.K. Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)6.3.4 Italy Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)6.3.5 Russia Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026) 7 Asia-Pacific Cell Freezing Media for Cell Therapy Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Cell Freezing Media for Cell Therapy Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Cell Freezing Media for Cell Therapy Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.2 Japan Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.3 South Korea Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.4 India Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.5 Australia Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.6 Taiwan Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.7 Indonesia Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.8 Thailand Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.9 Malaysia Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.10 Philippines Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)7.3.11 Vietnam Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026) 8 Latin America Cell Freezing Media for Cell Therapy Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Cell Freezing Media for Cell Therapy Sales Market Share by Country (2015-2020)8.1.2 Latin America Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Cell Freezing Media for Cell Therapy Sales Market Share by Country (2021-2026)8.2.2 Latin America Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)8.3.2 Brazil Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)8.3.3 Argentina Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026) 9 Middle East and Africa Cell Freezing Media for Cell Therapy Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Cell Freezing Media for Cell Therapy Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Cell Freezing Media for Cell Therapy Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Cell Freezing Media for Cell Therapy Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026)9.3.3 U.A.E Cell Freezing Media for Cell Therapy Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Cell Freezing Media for Cell Therapy Business10.1 BioLife Solutions10.1.1 BioLife Solutions Corporation Information10.1.2 BioLife Solutions Description, Business Overview and Total Revenue10.1.3 BioLife Solutions Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.1.4 BioLife Solutions Cell Freezing Media for Cell Therapy Products Offered10.1.5 BioLife Solutions Recent Development10.2 Thermo Fisher Scientific10.2.1 Thermo Fisher Scientific Corporation Information10.2.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue10.2.3 Thermo Fisher Scientific Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.2.5 Thermo Fisher Scientific Recent Development10.3 Merck10.3.1 Merck Corporation Information10.3.2 Merck Description, Business Overview and Total Revenue10.3.3 Merck Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.3.4 Merck Cell Freezing Media for Cell Therapy Products Offered10.3.5 Merck Recent Development10.4 GE Healthcare10.4.1 GE Healthcare Corporation Information10.4.2 GE Healthcare Description, Business Overview and Total Revenue10.4.3 GE Healthcare Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.4.4 GE Healthcare Cell Freezing Media for Cell Therapy Products Offered10.4.5 GE Healthcare Recent Development10.5 Zenoaq10.5.1 Zenoaq Corporation Information10.5.2 Zenoaq Description, Business Overview and Total Revenue10.5.3 Zenoaq Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.5.4 Zenoaq Cell Freezing Media for Cell Therapy Products Offered10.5.5 Zenoaq Recent Development10.6 WAK-Chemie Medical10.6.1 WAK-Chemie Medical Corporation Information10.6.2 WAK-Chemie Medical Description, Business Overview and Total Revenue10.6.3 WAK-Chemie Medical Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.6.4 WAK-Chemie Medical Cell Freezing Media for Cell Therapy Products Offered10.6.5 WAK-Chemie Medical Recent Development10.7 Biological Industries10.7.1 Biological Industries Corporation Information10.7.2 Biological Industries Description, Business Overview and Total Revenue10.7.3 Biological Industries Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.7.4 Biological Industries Cell Freezing Media for Cell Therapy Products Offered10.7.5 Biological Industries Recent Development10.8 Akron Biotechnology10.8.1 Akron Biotechnology Corporation Information10.8.2 Akron Biotechnology Description, Business Overview and Total Revenue10.8.3 Akron Biotechnology Cell Freezing Media for Cell Therapy Sales, Revenue and Gross Margin (2015-2020)10.8.4 Akron Biotechnology Cell Freezing Media for Cell Therapy Products Offered10.8.5 Akron Biotechnology Recent Development 11 Cell Freezing Media for Cell Therapy Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Cell Freezing Media for Cell Therapy Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Cell Freezing Media for Cell Therapy Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis 12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Link:
Covid-19 Impact on Cell Freezing Media for Cell Therapy Market (2020-2026) - Science In Me
- RMS Sponsors the 5th Summit on Stem Cell Derived Islets - The Manila Times - October 30th, 2024
- Differentiation fate of a stem-like CD4 T cell controls immunity to cancer - Nature.com - October 30th, 2024
- Self-organization of stem cells into embryos: A window on early ... - October 24th, 2024
- Stemness and ROS: Redox Signaling and Regulation in Stem Cell Biology - Frontiers - October 24th, 2024
- Now its getting bloody in cardiac organoids - Nature.com - October 18th, 2024
- Embryonic stem cells - PMC - National Center for Biotechnology Information - October 15th, 2024
- They Were Made Without Eggs or Sperm. Are They Human? - The Atlantic - October 15th, 2024
- A novel investigation of NANOG and POU5F1 associations in the pluripotent characterization of ES-like and epiblast cells - Nature.com - October 15th, 2024
- Researchers uncover new mechanism of stem cell differentiation linked to cancer progression - News-Medical.Net - October 14th, 2024
- Stem Cells to Reverse Diabetes, the Spread of Marburg Virus and Map of a Fruit Fly Brain - Scientific American - October 14th, 2024
- Stem Cells Market Expectation Surges with Rising Demand and Changing Trends - openPR - October 11th, 2024
- How close are we to perfecting synthetic stem cells? - The Mancunion - October 10th, 2024
- Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart - Nature.com - October 10th, 2024
- Revolutionary stem cell transplant successfully closes vision-threatening holes in the eye - Study Finds - October 4th, 2024
- Early human development and stem cell-based human embryo models - October 4th, 2024
- No partner, no problem: How people in the future might be able to have children with themselves - RNZ - October 4th, 2024
- Californias Billion-Dollar Stem Cell Initiatives End In Failure OpEd - Eurasia Review - October 4th, 2024
- The Future Of Stem Cell Therapy With Dr Adeel Khan - Style Magazines - October 4th, 2024
- New Study Mapping Stem Cells Reveals Molecular Choreography Behind ... - September 30th, 2024
- Stem Cell Research at Johns Hopkins Institute of Basic Biomedical ... - September 30th, 2024
- Zack Wang , PhD - Hopkins Medicine - September 30th, 2024
- Jennifer Hartt Elisseeff , PhD - Hopkins Medicine - September 30th, 2024
- Dr. Elias Zambidis, MD, PhD - Baltimore, MD - Pediatric Cellular ... - September 30th, 2024
- Alan David Friedman , MD - Hopkins Medicine - September 30th, 2024
- Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research - Nature.com - September 30th, 2024
- Human Embryonic Stem Cells Market Insights and Growth Trends: Leading Players and Future Projections to 2031 - WhaTech - September 26th, 2024
- Zac Efron says stem cell therapy helped him heal from The Iron Claw injuries - Daily Mail - September 25th, 2024
- The Role of Stem Cell Therapy in the Future of Personalized Medicine - HIT Consultant - September 25th, 2024
- Stem Cell Therapy Market to Exceed $831.9 Million by 2032 with 17.2% CAGR Growth - openPR - September 14th, 2024
- Brain Builders: How Stem Cell Research Is Rewriting the Genetic Code of Mental Health - SciTechDaily - September 14th, 2024
- Pausing biological clock could give boost to lab-produced blood stem cells - Phys.org - September 10th, 2024
- Alive and Kicking: Watch this space on controversy-free stem-cell ... - September 8th, 2024
- After 25 years of hype, embryonic stem cells still don't cure for ... - September 8th, 2024
- Human embryonic stem cells: origin, properties and applications - September 8th, 2024
- Livestock embryonic stem cells for reproductive biotechniques and ... - September 8th, 2024
- Marinexcell: Our Vision Is To Create a Sustainable and Reliable Source of Seafood Products - vegconomist - the vegan business magazine - September 6th, 2024
- How cells enter the germline at the right time and place during embryonic development - MRC Laboratory of Molecular Biology - September 6th, 2024
- Diabetes took over her life, until a stem cell therapy freed her - redlakenationnews.com - August 31st, 2024
- Diabetes took over her life, until a stem cell therapy freed her - The Washington Post - August 27th, 2024
- New way to extend shelf life of blood stem cells will improve gene therapy - University of Cambridge news - August 20th, 2024
- The anti-aging tech guy is now shooting $25,000 worth of stem cells into his knees. Here's why - Quartz - August 16th, 2024
- Substrates mimicking the blastocyst geometry revert pluripotent stem cell to naivety - Nature.com - August 12th, 2024
- Delivery of stem cell therapy for Parkinsons safe in primate trial - Parkinson's News Today - August 2nd, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report - July 31st, 2024
- Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation - July 31st, 2024
- Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its... - July 31st, 2024
- Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference - July 31st, 2024
- Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors - July 31st, 2024
- electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 - July 31st, 2024
- GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 - July 31st, 2024
- New Study: These Bizarre Blood-Sucking Fish Have a Jaw-Dropping Evolutionary Origin - SciTechDaily - July 30th, 2024
- Surgeon Turns to Stem Cells to Help Treat Autism and Immune Disorders - The Well News - July 22nd, 2024
- Study identifies epigenetic 'switches' that regulate the developmental trajectories of single cells - Medical Xpress - July 22nd, 2024
- German Man Likely 'Cured' of HIV With Stem Cell Therapy - Times Now - July 22nd, 2024
- CervoMed to Participate in the Emerging Growth Conference - July 18th, 2024
- Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives - July 18th, 2024
- Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification - July 18th, 2024
- Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of... - July 18th, 2024
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of... - July 18th, 2024
- Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study - July 18th, 2024
- New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic - July 18th, 2024
- Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion - July 18th, 2024
- Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma - July 18th, 2024
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal - July 18th, 2024
- Scorpius Holdings Announces Reverse Stock Split - July 18th, 2024
- Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines - July 18th, 2024
- Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe... - July 18th, 2024
- Q2 2024 Revenue and Business Highlights, Guidance Upgrade - July 18th, 2024
- Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line... - July 18th, 2024
- Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance - July 18th, 2024
- BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of... - July 18th, 2024
- Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and... - July 18th, 2024
Recent Comments